Joseph Cleveland – Meadowbrook
P: (516) 377-8200 | F: (516) 377-8233

Posts Tagged ‘Joseph Cleveland’

FDA Expands TAVR Indication to Low-Risk Patients

Hot off the Press…The U.S. Food and Drug Administration (FDA) approves an expanded indication for several transcatheter heart valves (Sapien 3, Sapien 3 Ultra, CoreValve Evolut R and CoreValve Evolut PRO) to include patients with severe aortic valve stenosis at low surgical risk. According to the FDA, the incidence of aortic valve stenosis increases with age.…

Read More